About Novacyt
Novacyt is a company based in Velizy-villacoublay (France) founded in 2005.. Novacyt has completed 4 acquisitions, including IT-IS, Lab21 and Primerdesign. Novacyt operates in a competitive market with competitors including Guardant Health, Natera, Foundation Medicine, ArcherDX and Prenetics, among others.
- Headquarter Velizy-villacoublay, France
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Novacyt Sas
-
Annual Revenue
$24.09 M (USD)89.89as on Dec 31, 2024
-
Net Profit
$-51.25 M (USD)-51.64as on Dec 31, 2024
-
EBITDA
$-11.05 M (USD)22.09as on Dec 31, 2024
-
Latest Funding Round
$4.72 M (USD), Debt – Conventional
May 30, 2018
-
Investors
Kreos Capital
& 1 more
-
Employee Count
Employee Count
-
Investments & Acquisitions
IT-IS
& 3 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Novacyt
Novacyt is a publicly listed company on the EURONEXT with ticker symbol ALNOV in France, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Unlock access to complete
Unlock access to complete
Funding Insights of Novacyt
- Total Funding Total Funding
- Total Rounds 9
- Last Round Debt – Conventional — $4.7M
-
First Round
First Round
(10 Dec 2014)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2018 | Amount | Debt – Conventional - Novacyt | Valuation |
investors |
|
| Oct, 2017 | Amount | Post-IPO - Novacyt | Valuation |
investors |
|
| Jun, 2017 | Amount | Post-IPO - Novacyt | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Novacyt
Novacyt has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Kreos Capital and Eiffel Investment Group. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture debt is provided to growth-stage companies across multiple sectors.
|
Founded Year | Domain | Location | |
|
Private equity and private debt firm focused on multiple sector
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Novacyt
Novacyt has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include IT-IS, Lab21 and Primerdesign. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Clinical research, trials, and biomarker discovery services are offered.
|
2013 | ||||
|
Personalised diagnostic testing for diseases and predisposition is specialised in.
|
2005 | ||||
|
Real-time PCR kits and reagents using its technology
|
2005 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Novacyt
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Novacyt Comparisons
Competitors of Novacyt
Novacyt operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, Natera, Foundation Medicine, ArcherDX and Prenetics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Digital sequencing technology for cancer detection is developed.
|
|
| domain | founded_year | HQ Location |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| domain | founded_year | HQ Location |
Genomics-based diagnostic tests for cancer are provided.
|
|
| domain | founded_year | HQ Location |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| domain | founded_year | HQ Location |
Health risks are identified through online genetic and diagnostic testing.
|
|
| domain | founded_year | HQ Location |
Manufacturer of products in the areas of veterinary diagnostics, life sciences, DNA testing, and drug testing
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Novacyt
Frequently Asked Questions about Novacyt
When was Novacyt founded?
Novacyt was founded in 2005 and raised its 1st funding round 9 years after it was founded.
Where is Novacyt located?
Novacyt is headquartered in Velizy-villacoublay, France. It is registered at Velizy-villacoublay, Ile-de-france, France.
What is the annual revenue of Novacyt?
Annual revenue of Novacyt is $24.09M as on Dec 31, 2024.
What does Novacyt do?
Novacyt was founded in 2005 in Velizy Villacoublay, France, as a developer of cytology instruments and consumables focused on oncology and infectious disease sectors. Cellular diagnostics are emphasized through a portfolio of products and services for cancer and infectious disease applications. Operations center on proprietary platform technology NovaPrep, an automated liquid cytology instrument used for cancer diagnosis. The company operates primarily in the medical diagnostics industry.
Who are the top competitors of Novacyt?
Novacyt's top competitors include Guardant Health, Foundation Medicine and Natera.
Is Novacyt publicly traded?
Yes, Novacyt is publicly traded on EURONEXT under the ticker symbol ALNOV.
How many acquisitions has Novacyt made?
Novacyt has made 4 acquisitions, including IT-IS, Lab21, and Primerdesign.
Who are Novacyt's investors?
Novacyt has 2 investors. Key investors include Kreos Capital, and Eiffel Investment Group.
What is Novacyt's ticker symbol?
The ticker symbol of Novacyt is ALNOV on EURONEXT.